Financial Disdosures and Products
None ofthe authors has a financial interest to declare in relation to the content ofthis work. This work was supported by grants from the Jap<m Orthopaedics and Traumatology Research Kenichi Nakano conducted data analysis.
Yasuaki Nakanishi conducted data analysis.
Tadanobu Onishi conducted data analysis.
Akira Kido conducted biological analysis.
Yusuke Inagakijointly interpreted the results.
Yasuhito Tanaka interpreted the results.
All authors have approved the manuscript for submission.
3

INTRODUCTION
Flap surgery is a highly effective technique used for various tissue grafting or reconstruction applications. However, donor flaps are limited with respect to the area comprising reliable vascularity and donor-site morbidity. Recent studies have shown that bone marrow stromal cells (BMSCs) are abundant and produce growth factors, including hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF). 1 -3 Multipotent stromal cells within the BMSC population are capable of differentiating into endothelial; therefore, application of BMSCs to flap surgery represents a promising approach. 4 However, transplantation of BMSCs is limited owing to their poor survival within ischemic tissues. 5 Consequently, a more effective method of BMSC transplantation is required.
With recent advances in tissue engineering, cell sheets can be produced from BMSCs, using ascorbic acid phosphate (vitamin C). 6 Vitamin C induces biosynthesis of collagen and extracellular matrix (ECM) by changing the physiological environment of immature cells, contributing to constitution of in vivo cell-sheets. The cell sheets can be transplanted without a scaffold because of the plentiful ECM included, which preserves cell-cell junctions and mimics the cellular microenvironment in terms of mechanical, chemical, and biological properties.
Because angiogenesis by BMSCs is stimulated under hypoxia, through increased expression of angiogenic factors, 7 • 8 hypoxic conditions may also increase the angiogenic potential of BMSC sheets.
Cell-sheet engineering has provided an alternative approach to tissue engineering in corneal, 9 myocardial, 10 hepatic, u periodontal, 12 and musculoskeletal tissues, 13 • 14 To date however, there have been no reports regarding the application of cell-sheets to skin flaps. We hypothesized that BMSC sheets cultured under hypoxic conditions may enhance the survival of skin flaps. The purpose of this study was to determine whether application of BMSC-sheets could maintain a greater area of survival and enhance the expression of angiogenic factors in skin flaps.
MATERIALS AND METHODS
Primary culture
BMSCs were obtained by flushing the femur shafts of a 7 -week-old male Fisc her 344 (F344) rat with 10 ml of culture medium. The released cells were collected in two flasks (T7 5 -cm 2 culture flasks; Falcon BD, Franklin Lakes, NJ, USA) containing 10 ml of standard medium, comprising minimal essential medium (MEM; Nacalai Tesque Inc., Kyoto, Japan) supplemented with 15% fetal bovine serum (FBS; JRH Bioscience Inc., Lenexa, KS, USA) and 1% antibiotics (1 0000 U/ml penicillin and 10,000 11g/ml streptomycin; Nacalai Tesque Inc.). The cells were cultured in an incubator under 5% C02 at 37°C. On reaching confluence, the primary-cultured cells were detached from the flasks using trypsin/EDTA (Gibco, Invitrogen, Carlsbad, CA, USA). The research protocol was approved by the Institutional Animal Care and Use Committee ofNara Medical University, and followed all appropriate guidelines.
Differentiation assay
A total of three F344 rats (7 weeks old) were used. After the primary culture, BMSCs were seeded at 1x10 4 cells/cm 2 in 6-well plates (9.6 cm 2 ; Falcon BD) and cultured for 2 weeks in media for osteogenic, adipogenic and chondrogenic differentiation:
1) The osteogenic differentiation (OD) medium included MEM, 15% FBS, 82 ).lg/ml L-ascorbic acid phosphate magnesium salt n-hydrate (vitamin C, Wako Pure Chemical Industries, Kyoto, Japan), 10 nM dexamethasone (Dex, Sigma-Aldrich, St. Louis, MO) and 10 mM ~-glycerophosphate disodium salt pentahydrate (~-GP, Calbiochem, Boston, MA). OD was identified with Alizarin red S (0.25 g Alizarin red S in 50 ml of O.lM barbital buffer; Nacalai Tesque) for calcium deposition and fast red violet B (Nacalai Tesque) for staining of alkaline phosphatase (ALP) activity. BMSCs were cultured in standard medium in 6-well plates as a control. Staining was compared between differentiated BMSCs and control BMSCs.
BMSC-sheet preparation
To create BMSC sheets, primarily cultured cells harvested from three rats were seeded at 1 x 10 4 cells/cm 2 in 6-cm dishes (60x 15 mm; Falcon BD) containing vitamin C and cultured until they reached confluence (approximately 2 weeks). The BMSC sheets were randomly divided into four different culture groups (n=l8 per group): The N-N group was cultured under normoxia for 2 weeks; the H-H group was cultured under hypoxia for 2 weeks; the N-H group was cultured under normoxia for 1 week followed by hypoxia for 1 week; and the H-N group was cultured under hypoxia for 1 week followed by normoxia for 1 week. For hypoxic conditions, cells were cultured in a gas mixture composed of 90% N2, 5% COz, and 5% 0 2 using a special incubator. The BMSC-sheets were rinsed twice with phosphate-buffered saline (PBS; Gibco) and then lifted using a cell scraper (Fig. 1 ).
Eighteen BMSC sheets in each group were evaluated for their in vitro angiogenic potential by quantitative real-time polymerase chain reaction (qRT-PCR) using an ABI PRISM 7700
Sequence Detection System (Applied Biosystems, Foster City, CA, USA). RNA was harvested using an RNeasy Mini Kit (Qiagen Inc., Valencia, CA, USA) according to the manufacturer's protocol, and converted into cDNA. Target mRNA levels ofVEGF-A, Epidermal Growth Factor (EGF), Platelet-Derived Growth Factor B (PDGF-B), and Insulin-like Growth Factor 1 (IGF-1) were compared after normalization to ~-actin mRNA levels, which were used to adjust for differences in the efficiency of reverse transcription between samples. The mRNA expression levels were assessed using the respective pnmers and probe set purchased from Applied Biosystems: VEGF-A: Rn01511602_m1; ~-actin: Rn00667869 _m1; EGF: Rn00563336_ml; PDGF-B: Rn01502596_m1; and IGF-1: Rn00710306_ml. Additionally, 10 skin samples (5x5 mm) from each group were collected from the flaps at 3 cm distal to the flap base. After homogenization, VEGF-A and basic fibroblast growth factor (bFGF) gene expression levels were determined to assess the in vivo angiogenic potential of the flaps by qRT-PCR. Target mRNA levels were compared after normalization to ~-actin mRNA levels, which were used to adjust for differences in the efficiency of reverse transcription between samples. The mRNA expression level was measured using the respective primers and probe set purchased from Applied Biosystems (USA)): bFGF: Rn00570809 _ ml.
Immunohistochemical analysis
For histological evaluation, four rats from the each group were deeply anesthetized and transcardially perfused with PBS, followed by 4% paraformaldehyde m 0.1 M PBS. We 15 
RESULTS
Differentiation assay
Alizarin redS and ALP staining ofBMSCs cultured in OD medium andAlcian blue staining of those cultured in CD medium were strongly positive, but very weak in control BMSCs. Oil red 0 staining revealed lipid droplets in BMSCs cultured in AD medium (Fig. 3) , whereas cells grown in control medium were not stained.
In vitro study
Expression levels of mRNAs for all angiogenic factors were high in the H-H group, but low in the N-N group (Fig. 4) . The VEGF-A level in the H-H group was significantly higher than those in the other three groups, and was significantly higher in the N-H group than in the N-N and H-N groups. The EGF and PDGF-B levels in the H-H group were significantly higher than those in theN-Nand N-H groups, and there was a significant difference between the PDGF-B levels in the H-N and N-N groups. There was no significant difference in EGF and PDGF-B levels between the H-N and H-H groups, but these levels in the H-H group showed a tendency 12 to be higher than those in the H-N group. There was no significant difference in the expression level ofiGF-1 between any two groups. Thus, we conducted the next in vivo experiment using BMSC sheets from the H-H group.
In vivo study
The H-H group BMSC sheets were used for in vivo studies because they exhibited high levels of all angiogenic factors in the in vitro study. On day 7 after implantation, regions of survival and necrosis were clearly demarcated, and neither infection nor wound dehiscence was observed in all flaps.
The mean flap survival percentage was 51.5±3.3% in the control group and 71.6±2.3% in the BMSC-sheet group (Fig. 5) , with a significant difference between the two groups (p<O.OOl).
The ICC value of three examiners' measurement data was 0.996, indicating almost perfect agreement of the measurement.
VEGF-A and bFGF gene expression levels in tissues from the BMSC-sheet group were significantly higher than those from the control group (p=O.O 12 and p=0.023, respectively, Fig.   6 ).
Immunohistochemical analysis
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In immunostaining for PECAM -1/CD31, PECAM -1-positive microvessels (circular blue and green areas) were observed in the panniculus camosus layer of BMSC sheets, in comparison with controls (Fig. 7) . There was no marked difference in the number ofPECAM-1-positive microvessels among the basal, middle and distal regions of surviving skin flap.
DISCUSSION
The oxygen concentration in bone marrow is known to be lower (1-7%) than that in the atmosphere, and hypoxia during culture of BMSCs enhances their proliferation, expression of angiogenic factors, and paracrine effects. 16 However, no reports are available on how levels of angiogenic factors in BMSC sheets change under hypoxic conditions. In the current study, in vitro experimentation demonstrated that hypoxic conditions m the secondary culture significantly enhanced gene expression ofVEGF-A, EGF, and PDGF-B factors in BMSC sheets.
The H-H group, which was cultured under hypoxia for 2 weeks, had the highest expression levels. These results indicate that hypoxic conditions may enhance the angiogenic potential during formation ofBMSC sheets.
We speculated that BMSC sheets cultured under hypoxia could enhance the angiogenic factors expression, leading to maintenance of a larger area of transplanted tissue. Previous investigators have reported that BMSCs cultured under hypoxia show increased production of angiogenic factors, and resistance to oxidative stress and cell-adhesion molecules of bone marrow cellsY- 19 Moreover, hypoxic culture has been demonstrated to increase skin-regenerative potentiai.2° Most of these studies report viability ofBMSCs in culture for only 24 hours. In the current study, hypoxic conditions led to increasing levels of angiogenic factors in BMSC sheets during culture for 2 weeks. We consider that BMSC sheets require more time than BMSCs to be influenced by hypoxic conditions because of the abundant ECM within the BMSC sheets. There are several limitations to this study. The exact locations of the BMSC after transplantation were not clearly demonstrated. Further studies are needed to prove whether neovascularization is enhanced by the transplanted BMSCs, and to purify the cell and ECM components of the BMSC sheets using cell-labeling techniques and collagen analyses.
CONCLUSION
Using the BMSC-sheet transplantation technique under hypoxic condition, enhanced angiogenic potential to local tissue areas was observed in the absence of a scaffold. This The mean bFGF mRNA level evaluated by qRT-PCR was higher in the flaps from the BMSC-sheet group than in those from the control group (n=10; p<0.05). 
